FINAL REMINDER REGN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Regeneron Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit
Portfolio Pulse from
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. for alleged violations of federal securities laws. The lawsuit covers investors who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 10, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. for alleged securities law violations, potentially impacting its stock price.
The lawsuit alleges violations of federal securities laws, which could lead to financial penalties or settlements, negatively impacting Regeneron's stock price. Legal issues often create uncertainty, leading to potential short-term price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100